Drug Usage Trend study

Anti-hypertensive drugs

Of the 30 branded anti-hypertensive drugs, Olmetec had the highets usage rate at 74%, followed by Micardis (69%) and Blopress (66%).
For the rate of product awareness, Olmetec was the highest and followed by Blopress. (See graph below). As for future usage rate of main products that the respondents expect to increase in the future, Azilva and Aimix were significantly high.
Also, 30% of the respondents have plans to start using a new product within the next six months.

<Outline>
  • Target samples: Target samples: N=518 with internal medicine doctors, gastroenterologists, cardiologists, endocrinologists, nephrologists, and neurosurgeons
  • Study period: May ~ June 2014
  • Studied products: Nu-Lotan, Blopress, Diovan, Micardis, Olmetec, Irbetan, Avapro, Azilva, Preminent, Ecard, Co-DIO, Micombi, Irtra, and “Other” ; ARB+CA (compound drugs ), CA(including compounds), β blockers
  • average monthly number of patients and prescriptions, product awareness and usage rates, product satisfaction, the reasons for use, future usage expectations (short-term), intentions of switching, rate of not switching to generic products, and reasons for adopting new products
  • SSRI Drug Usage Trend study is a physician study that started in 1984, which focuses on products in various therapeutic areas